Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bunge Global SA (NYSE: BG) SEC filings page brings together the company’s regulatory disclosures, giving investors and analysts direct access to the documents that explain its agribusiness and food operations in detail. As a Swiss-incorporated issuer with registered shares listed on the New York Stock Exchange, Bunge files annual, quarterly and current reports with the U.S. Securities and Exchange Commission under Commission File Number 000-56607.
Through Forms 10-K and 10-Q, Bunge provides information on its segments, including Agribusiness, Refined and Specialty Oils, Milling and Corporate and Other, and, more recently, its value-chain-based segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. These reports describe how Bunge’s grain origination, oilseed processing and refining, and milling activities contribute to its results, and present both GAAP and non-GAAP metrics such as Segment EBIT and Adjusted Total EBIT.
Current reports on Form 8-K offer timely updates on material events, including earnings releases, changes in segment reporting, capital markets transactions, amendments to revolving credit agreements, expansions of commercial paper and securitization programs, and share capital changes following repurchases. Filings also document governance matters, such as executive transitions and amendments to the Articles of Association.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand changes in Bunge’s capital structure, liquidity facilities, segment performance and risk disclosures. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K and related exhibits appear promptly, while insider transaction reports on Form 4, when filed, can be used to monitor trading by directors and officers. This combination of primary documents and AI explanations allows users to navigate Bunge’s complex agribusiness value chains through its official SEC record.
Bunge Global SA director WINSHIP HENRY WARD IV reported an acquisition of common stock-linked awards. On March 3, 2026, he received 15.0000 restricted stock units at a reference price of $116.8300 per share, classified as a grant or award acquisition under the company’s long-term incentive plans.
According to the filing, these units were acquired pursuant to a dividend feature in Bunge Global’s long-term incentive programs. After this transaction, Ward’s direct holdings totaled 33,456.7968 shares of Bunge Global SA common stock.
Bunge Global SA director Eliane Aleixo Lustosa de Andrade acquired 15 restricted stock units of common stock on March 3, 2026, valued at $116.83 per unit. These units were credited pursuant to a dividend feature under Bunge’s long-term incentive plans, bringing her directly owned total to 6,558 shares.
Bunge Global SA director Linda P. Jojo reported an acquisition of company equity through a compensation feature. On March 3, 2026, she received 15 restricted stock units under a dividend feature in the company’s long-term incentive plans. Following this award, she directly holds 2,586 shares of Bunge Global common stock.
Bunge Global SA director Monica Houle McGurk reported an acquisition of common stock-linked awards. On March 3, 2026, she received 15.0000 shares-equivalent of Common Stock at a reference price of $116.8300 per share as a grant, award, or other acquisition.
According to the footnote, these represent restricted stock units acquired pursuant to a dividend feature under Bunge Global SA’s long-term incentive plans. After this grant, she held 6,072.0000 shares of Common Stock in total in direct ownership.
Bunge Global SA director Adrian Isman acquired 13 restricted stock units relating to Common Stock on March 3, 2026. These units were credited under a dividend feature in the company’s long-term incentive plans at $116.83 per share, bringing his directly held Common Stock to 2,210 shares.
Bunge Global SA director Anne Jensen reported an acquisition of 13 shares of common stock on March 3, 2026. The filing describes these as restricted stock units received under a dividend feature in the company’s long-term incentive plans. After this grant, she directly holds 2,210 shares.
Bunge Global SA director Christopher Mahoney reported acquiring 13 restricted stock units of common stock on March 3, 2026. These units were credited under a dividend feature in the company’s long-term incentive plans and increased his directly held common stock-related position to 7,210 shares-equivalent.
Walt Markus reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Markus Walt received an award of 13 shares of common stock on March 3, 2026. These were restricted stock units credited under a dividend feature in the company’s long-term incentive plans. After this grant, he directly holds 2,210 common shares.
Bunge Global SA director Mark N. Zenuk reported an equity award on common stock. On March 3, 2026 he acquired 28 restricted stock units, valued at $116.83 per share, under a dividend feature of the company’s long-term incentive plans. Following this award, he held 21,899 common shares directly and 6,500 shares indirectly through the Zenuk Family Living Trust u/a/d 09/01/2015.
Bunge Global SA reported that Chief Human Resources Officer Kellie Sears acquired additional equity through a stock-based award. On March 3, 2026, she received 109 restricted stock units, described as being acquired pursuant to a dividend feature under the company’s long-term incentive plans, at a value of $116.83 per share. After this grant, she directly held 25,637 shares of common stock.